Menu
Log in



Your Resource for Neurotherapeutics Discovery and Development


  • Home
  • Annual Meeting

Annual Meeting Overview

BECOME A SUPPORTER  FINAL PROGRAM  

REGISTER TO ATTENDBOOK YOUR HOTEL ROOM

Join us as the American Society for Experimental Neurotherapeutics Annual Meeting (ASENT 2025) will be held at Hyatt Regency Bethesda, in Bethesda, MD from March 12-14, 2025. 

ASENT's 2025 Annual Meeting is the premier neuroscience and neurotherapeutics conference where senior leaders from healthcare payers, providers and prescribers, employers, investors, fast-growing startups, big pharma, policymakers, funders and innovation centers gather to improve the process of bringing neurotherapeutics to market.

The Meeting features 12 symposia, which address therapeutic advances in a broad range neurologic disease states, processes and delivery methods; as well as interactive poster presentations, ASENT's celebrated pipeline presentations, and live discussion with speakers at the end of each day. 

2025 Meeting Highlights 

    • 12 - 16 Scientific Symposia featuring Neuroscience leaders from Industry, Academia, FDA, NIH, and Advocacy
    • DEBATE: Featuring a hot topic and current data
    • CNS PIPELINE Presentations
    • CAREER DINNER Featuring Guest Speakers
    • Interactive Poster Discussions
    • Sponsored Symposia from Innovation Leaders
    • Live Discussions in Breakout Rooms with Speakers
    • 2nd Annual Neurotherapeutics Clinical Trial Course - LIVE  (application only)


    This year our program will include symposia on:

    • Gene targeted therapy for Epilepsy
    • Universal Framework for Staging of Neurodegenerative Diseases
    • A Broader Look at Patient Focused Drug Development
    • Immunotherapy of Neurodegenerative Disorders
    • An Update on Pediatric Neurotherapeutics
    • Novel Therapies in Duchenne and Becker’s Muscular Dystrophy
    • Global Neuroinfectious Disease
    • Autoimmune Therapeutics presented inconjunction with the Japanese Society of Neurological Therapeutics
    • Diversity and Equity in Clinical Trials
    • ”Tell me about it” speech analysis in Neurodegenerative Diseases
    • Update on Pain Therapeutic Opportunities
    • Updates in Neurovascular and Stroke Therapeutics
    • Interactive Poster Discussions
    • Dynamic Pipeline Presentations
    • Live Discussions in Breakout Rooms with Speakers
    • And much, much more!


    Meeting Location

    Hyatt Regency Bethesda, Bethesda MD

    BOOK YOUR ROOM


    Who Attends

    50% of attendees are practicing physicians| Physician-Scientists | Neurologists | Neuroscientists | Drug and Device Companies | Fellows | Post-docs | Founders | Funders | Industry Leaders | Nonprofit Organizations and Advocacy Groups | Journal Editors | Representatives from NIH, NIA, NIDA, NINDS and FDA

    The 2025 meeting will feature a high number of junior faculty and trainees as attendees at our clinical trials course and neurotherapeutic drug discovery course are welcome to attend the annual meeting at a discounted cost. 

    Neurology students and residents interested in neurotherapeutic development will benefit from the insight of senior investigators and leaders in industry, while private practice neurologists considering entering the clinical trial space will benefit from lessons learned by ASENT leadership. The Annual Meeting features career development sessions that offer strategies for achieving professional success in the field of neurotherapeutics. 

    Cancellation Policy

    You may cancel your registration for a refund through February 28, 2025. Cancellations will be refunded less a $50 cancellation fee. No refunds will be granted for cancellations on March 1, 2025, and after.


    Upcoming events

    No events available

    Powered by Wild Apricot Membership Software